Lab
Colorado Pathology Consultants PC
Colorado Pathology Consultants PC was paid $13.20M by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 17% of everything it billed.
33Billing provider infoCOLORADO PATHOLOGY CONSULTANTS PC
DENVER, CO 80209
DENVER, CO 80209
33aNPI1952373953assigned 02/03/2006
33bProvider typeClinical Medical Laboratory
28Total paid$13.20M
24GClaims464,795
24DCodes billed31
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Colorado
Rank by total paid#6 of 91
Median peer was paid$53K
This provider vs. median248×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WHEELER, DARREN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 58,056 | $1.87M | |
| 2019 | 63,664 | $1.90M | |
| 2020 | 62,121 | $1.80M | |
| 2021 | 67,098 | $1.76M | |
| 2022 | 68,912 | $1.99M | |
| 2023 | 42,201 | $1.10M | |
| 2024incomplete | 102,743 | $2.78M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 17% | 79,004 | 66,510 | $2.28M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 17% | 78,971 | 66,477 | $2.26M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 15% | 64,770 | 55,419 | $2.00M |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 12% | 92,378 | 79,491 | $1.59M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 11% | 26,549 | 15,306 | $1.42M |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 6.9% | 17,046 | 14,678 | $908K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 6.0% | 27,865 | 24,590 | $796K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 5,597 | 4,091 | $371K |
| 87799 | 2.0% | 2,261 | 1,850 | $261K | |
| 87481 | 1.5% | 5,563 | 5,167 | $201K | |
| 87511 | 1.4% | 5,414 | 5,063 | $189K | |
| 88141 | 1.1% | 9,750 | 9,029 | $139K |
19 more codes
| 87512 | <1% | 2,267 | $86K | |
| 88142 | <1% | 4,659 | $80K | |
| 88342 | <1% | 2,820 | $77K | |
| 87625 | <1% | 2,493 | $69K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,516 | $60K |
| 81513 | <1% | 15,032 | $57K | |
| 87510 | <1% | 3,562 | $55K | |
| 87660 | <1% | 3,566 | $54K | |
| 87480 | <1% | 3,563 | $54K | |
| 87653 | <1% | 1,587 | $50K | |
| 88304 | <1% | 3,186 | $47K | |
| 85060 | <1% | 2,745 | $41K | |
| 88307 | <1% | 682 | $36K | |
| 88112 | <1% | 384 | $12K | |
| 82657 | <1% | 102 | $2K | |
| 87150 | <1% | 80 | $2K | |
| 88313 | <1% | 258 | $1K | |
| 87081 | <1% | 97 | $556.92 | |
| 88312 | <1% | 28 | $311.95 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWHEELER, DARREN (VICE PESIDENT)
Parent organizationAMERIPATH INC.
| Provider | Location | Paid |
|---|---|---|
| Ameripath New York LLC | Shelton, CT | $7.70M |
| Ameripath New York LLC | White Plains, NY | $4.88M |
| Ameripath Hospital Services-Florida LLC | Fort Myers, FL | $3.60M |
| Ameripath Florida LLC | Pompano Beach, FL | $3.50M |
| Diagnostic Pathology Services, INC. | Oklahoma City, OK | $2.94M |
| Ameripath New York, LLC | Clifton, NJ | $1.55M |
| Hoffman, MD, Associated Pathologists Chartered | Las Vegas, NV | $1.52M |
| Ameripath Cleveland INC | Twinsburg, OH | $749K |
| Ameripath Texas, INC. | Lewisville, TX | $712K |
| Institute for Dermatopathology, INC. | Newtown Square, PA | $636K |
| Ameripath Cincinnati INC | Cincinnati, OH | $603K |
| Ameripath Lubbock 501A Corporation | Lubbock, TX | $594K |
| Institute for Dermatopathology, INC. | Pittsburgh, PA | $522K |
| Ameripath Tucson INC | Tucson, AZ | $514K |
| Ameripath Kentucky INC | Lexington, KY | $458K |
| Ameripath Florida LLC | Fort Myers, FL | $415K |
| Ameripath Florida LLC | Altamonte Springs, FL | $332K |
| Dermatopathology of Wisconsin SC | Brookfield, WI | $304K |
| Phenopath Laboratories PLLC | Seattle, WA | $279K |
| Ameripath Lubbock 501A Corporation | Lubbock, TX | $186K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.